In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The price of Kairos Pharma Ltd (AMEX: KAPA) closed at $1.51 in the last session, down -29.11% from day before closing price of $2.13. In other words, the price has decreased by -$29.11 from its previous closing price. On the day, 2.86 million shares were traded. KAPA stock price reached its highest trading level at $1.89 during the session, while it also had its lowest trading level at $1.16.
Ratios:
We take a closer look at KAPA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.84 and its Current Ratio is at 2.84. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 25 ’24 when Murali Ramachandran bought 200 shares for $1.59 per share. The transaction valued at 318 led to the insider holds 133,057 shares of the business.
Samuelson Doug bought 2,500 shares of KAPA for $3,750 on Nov 22 ’24. The Chief Financial Officer now owns 60,796 shares after completing the transaction at $1.50 per share. On Nov 20 ’24, another insider, Yu John S, who serves as the CEO and Chairman of the company, bought 4,000 shares for $1.44 each. As a result, the insider paid 5,760 and bolstered with 5,341,837 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KAPA now has a Market Capitalization of 19398668 and an Enterprise Value of 17134092.
Stock Price History:
Over the past 52 weeks, KAPA has reached a high of $4.00, while it has fallen to a 52-week low of $0.85. The 50-Day Moving Average of the stock is -3.75%, while the 200-Day Moving Average is calculated to be -5.32%.
Shares Statistics:
According to the various share statistics, KAPA traded on average about 2.13M shares per day over the past 3-months and 11516190 shares per day over the past 10 days. A total of 12.85M shares are outstanding, with a floating share count of 6.14M. Insiders hold about 52.20% of the company’s shares, while institutions hold 0.35% stake in the company. Shares short for KAPA as of 1730332800 were 9605 with a Short Ratio of 0.00, compared to 1727654400 on 19423.
Earnings Estimates
Currently, 1 analysts are dedicated to thoroughly evaluating and rating the performance of Kairos Pharma Ltd (KAPA) in the stock market.The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between -$0.1 and -$0.1 for the fiscal current year, implying an average EPS of -$0.1. EPS for the following year is -$0.23, with 1.0 analysts recommending between -$0.23 and -$0.23.
